CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
A phase I study of an IDO-1 inhibitor (LY3381916) as monotherapy and in combination with an anti-PD-L1 antibody (LY3300054) in patients with advanced cancer
Authors
Johanna Bendell
Karim A. Benhadji
+16Â more
Thompson N. Doman
Violeta R. Galvao
Leena Gandhi
Sandaruwan Geeganage
Shadia Jalal
Nuria Kotecki
Bert H. O'Neil
Hans Prenen
Sylvie Rottey
Abhijoy Saha
Subha Suriyapperuma
Anna M. Szpurka
Perrine Vuagnat
Johan Wallin
Meng Xia
Xiaojian Xu
Publication date
1 January 2021
Publisher
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Institutional Repository Universiteit Antwerpen
See this paper in CORE
Go to the repository landing page
Download from data provider
c:irua:180494
Last time updated on 30/08/2022